Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Bipolar I Disorder”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Post-approval studies (Phase 4)WithdrawnNCT01495156
What this trial is testing

Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

Who this might be right for
Bipolar I Disorder
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT05977023
What this trial is testing

NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
China Medical University Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07185815
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Who this might be right for
SchizophreniaBipolar I DisorderMajor Depressive Disorder
Mapi Pharma Ltd. 24
Not applicableStudy completedNCT00006517
What this trial is testing

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Who this might be right for
Seasonal Affective DisorderMood DisordersDepression
New York State Psychiatric Institute 150
Testing effectiveness (Phase 2)Study completedNCT02722967
What this trial is testing

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Not applicableLooking for participantsNCT07108257
What this trial is testing

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

Who this might be right for
Treatment-Resistant DepressionBipolar Depression
Sunnybrook Health Sciences Centre 10
Not applicableStudy completedNCT01202604
What this trial is testing

A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.

Who this might be right for
Bipolar Disorder
AstraZeneca 294
Large-scale testing (Phase 3)Ended earlyNCT01467713
What this trial is testing

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Takeda 642
Not applicableStudy completedNCT03641300
What this trial is testing

Efficacy of Convulsive Therapies for Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Centre for Addiction and Mental Health 76
Large-scale testing (Phase 3)Study completedNCT00391222
What this trial is testing

Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium 585
Not applicableStudy completedNCT01263548
What this trial is testing

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Who this might be right for
Attention Deficit/Hyperactivity DisorderBipolar Disorder
University Health Network, Toronto 45
Testing effectiveness (Phase 2)Study completedNCT05339074
What this trial is testing

Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Joshua Rosenblat 41
Large-scale testing (Phase 3)Study completedNCT00037674
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434
Large-scale testing (Phase 3)WithdrawnNCT01372722
What this trial is testing

Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder

Who this might be right for
Bipolar Disorder
University Hospital, Bonn
Not applicableStudy completedNCT03919760
What this trial is testing

Early Psychosis Intervention - Spreading Evidence-based Treatment

Who this might be right for
First Episode PsychosisSchizophrenia, ChildhoodPsychosis+7 more
Centre for Addiction and Mental Health 100
Large-scale testing (Phase 3)Study completedNCT01977300
What this trial is testing

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

Who this might be right for
Bipolar I Disorder
University of British Columbia 159
Large-scale testing (Phase 3)Study completedNCT03259555
What this trial is testing

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I DisorderManic Episode
Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Not applicableLooking for participantsNCT06831435
What this trial is testing

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study

Who this might be right for
DepressionBipolar Affective DisorderSchizophenia Disorder+1 more
Peking University 325
Not applicableStudy completedNCT05965232
What this trial is testing

FIbrosis and Steatosis in Patients With Psychiatric Illness

Who this might be right for
Severe Bipolar I Disorder (Diagnosis)Bipolar I Disorder, Most Recent Episode Mixed, in RemissionDepression Psychotic Feature+1 more
Centre Hospitalier Esquirol 385
Testing effectiveness (Phase 2)Active Not RecruitingNCT07046494
What this trial is testing

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Who this might be right for
Bipolar 1 Disorder
Rapport Therapeutics Inc. 253
Next Page